Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
<p>Supplementary Figure 19. (A) Objective response rate, (B) progression-free survival, and (C) overall survival to PD-(L)1 immune checkpoint blockade monotherapy among patients with ATMMUT NSCLC, according to KEAP1 mutation. (D) Objective response rate, (E) progression-free survival, and (F)...
Сохранить в:
| Главный автор: | |
|---|---|
| Другие авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Опубликовано: |
2025
|
| Предметы: | |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
| _version_ | 1849927632032890880 |
|---|---|
| author | Biagio Ricciuti (14951247) |
| author2 | Arielle Elkrief (15055750) Joao Alessi (15561455) Xinan Wang (15561458) Yvonne Li (15561461) Hersh Gupta (15561464) Daniel M. Muldoon (15561467) Arrien A. Bertram (14954848) Federica Pecci (15561470) Giuseppe Lamberti (15024714) Alessandro Di Federico (15561473) Adriana Barrichello (15561476) Victor R. Vaz (15561479) Malini Gandhi (15561482) Elinton Lee (15561485) Geoffrey I. Shapiro (14961801) Hyesun Park (15561488) Mizuki Nishino (15561491) James Lindsay (15032271) Kristen D. Felt (15561494) Bijaya Sharma (15561497) Andrew D. Cherniack (14959412) Scott Rodig (15561500) Daniel R. Gomez (15561503) Narek Shaverdian (15561506) Mehrdad Rakaee (15561509) Chaitanya Bandlamudi (15047205) Marc Ladanyi (15050661) Pasi A. Janne (15561512) Adam J. Schoenfeld (15022025) Lynette M. Sholl (15032729) Mark M. Awad (14961722) Michael L. Cheng (15561515) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Biagio Ricciuti (14951247) Arielle Elkrief (15055750) Joao Alessi (15561455) Xinan Wang (15561458) Yvonne Li (15561461) Hersh Gupta (15561464) Daniel M. Muldoon (15561467) Arrien A. Bertram (14954848) Federica Pecci (15561470) Giuseppe Lamberti (15024714) Alessandro Di Federico (15561473) Adriana Barrichello (15561476) Victor R. Vaz (15561479) Malini Gandhi (15561482) Elinton Lee (15561485) Geoffrey I. Shapiro (14961801) Hyesun Park (15561488) Mizuki Nishino (15561491) James Lindsay (15032271) Kristen D. Felt (15561494) Bijaya Sharma (15561497) Andrew D. Cherniack (14959412) Scott Rodig (15561500) Daniel R. Gomez (15561503) Narek Shaverdian (15561506) Mehrdad Rakaee (15561509) Chaitanya Bandlamudi (15047205) Marc Ladanyi (15050661) Pasi A. Janne (15561512) Adam J. Schoenfeld (15022025) Lynette M. Sholl (15032729) Mark M. Awad (14961722) Michael L. Cheng (15561515) |
| author_role | author |
| dc.creator.none.fl_str_mv | Biagio Ricciuti (14951247) Arielle Elkrief (15055750) Joao Alessi (15561455) Xinan Wang (15561458) Yvonne Li (15561461) Hersh Gupta (15561464) Daniel M. Muldoon (15561467) Arrien A. Bertram (14954848) Federica Pecci (15561470) Giuseppe Lamberti (15024714) Alessandro Di Federico (15561473) Adriana Barrichello (15561476) Victor R. Vaz (15561479) Malini Gandhi (15561482) Elinton Lee (15561485) Geoffrey I. Shapiro (14961801) Hyesun Park (15561488) Mizuki Nishino (15561491) James Lindsay (15032271) Kristen D. Felt (15561494) Bijaya Sharma (15561497) Andrew D. Cherniack (14959412) Scott Rodig (15561500) Daniel R. Gomez (15561503) Narek Shaverdian (15561506) Mehrdad Rakaee (15561509) Chaitanya Bandlamudi (15047205) Marc Ladanyi (15050661) Pasi A. Janne (15561512) Adam J. Schoenfeld (15022025) Lynette M. Sholl (15032729) Mark M. Awad (14961722) Michael L. Cheng (15561515) |
| dc.date.none.fl_str_mv | 2025-11-25T13:28:55Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30709318 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_19_from_Clinicopathologic_Genomic_and_Immunophenotypic_Landscape_of_i_ATM_i_Mutations_in_Non_Small_Cell_Lung_Cancer/30709318 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Genetic biomarkers DNA Damage and Repair DNA repair Lung Cancer Precision Medicine Translational Research |
| dc.title.none.fl_str_mv | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Supplementary Figure 19. (A) Objective response rate, (B) progression-free survival, and (C) overall survival to PD-(L)1 immune checkpoint blockade monotherapy among patients with ATMMUT NSCLC, according to KEAP1 mutation. (D) Objective response rate, (E) progression-free survival, and (F) overall survival to PD-(L)1 immune checkpoint blockade in combination with platinum doublet chemotherapy among patients with ATMMUT NSCLC, according to KEAP1 mutation status</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_3812402e3171b1a640a60cde8432f127 |
| identifier_str_mv | 10.1158/1078-0432.30709318 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30709318 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung CancerBiagio Ricciuti (14951247)Arielle Elkrief (15055750)Joao Alessi (15561455)Xinan Wang (15561458)Yvonne Li (15561461)Hersh Gupta (15561464)Daniel M. Muldoon (15561467)Arrien A. Bertram (14954848)Federica Pecci (15561470)Giuseppe Lamberti (15024714)Alessandro Di Federico (15561473)Adriana Barrichello (15561476)Victor R. Vaz (15561479)Malini Gandhi (15561482)Elinton Lee (15561485)Geoffrey I. Shapiro (14961801)Hyesun Park (15561488)Mizuki Nishino (15561491)James Lindsay (15032271)Kristen D. Felt (15561494)Bijaya Sharma (15561497)Andrew D. Cherniack (14959412)Scott Rodig (15561500)Daniel R. Gomez (15561503)Narek Shaverdian (15561506)Mehrdad Rakaee (15561509)Chaitanya Bandlamudi (15047205)Marc Ladanyi (15050661)Pasi A. Janne (15561512)Adam J. Schoenfeld (15022025)Lynette M. Sholl (15032729)Mark M. Awad (14961722)Michael L. Cheng (15561515)CancerMolecular and Cellular BiologyCancer Detection and DiagnosisTherapeutic Research and DevelopmentClinical Research and TrialsBiomarkersGenetic biomarkersDNA Damage and RepairDNA repairLung CancerPrecision MedicineTranslational Research<p>Supplementary Figure 19. (A) Objective response rate, (B) progression-free survival, and (C) overall survival to PD-(L)1 immune checkpoint blockade monotherapy among patients with ATMMUT NSCLC, according to KEAP1 mutation. (D) Objective response rate, (E) progression-free survival, and (F) overall survival to PD-(L)1 immune checkpoint blockade in combination with platinum doublet chemotherapy among patients with ATMMUT NSCLC, according to KEAP1 mutation status</p>2025-11-25T13:28:55ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30709318https://figshare.com/articles/figure/Supplementary_Figure_19_from_Clinicopathologic_Genomic_and_Immunophenotypic_Landscape_of_i_ATM_i_Mutations_in_Non_Small_Cell_Lung_Cancer/30709318CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307093182025-11-25T13:28:55Z |
| spellingShingle | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer Biagio Ricciuti (14951247) Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Genetic biomarkers DNA Damage and Repair DNA repair Lung Cancer Precision Medicine Translational Research |
| status_str | publishedVersion |
| title | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| title_full | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| title_fullStr | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| title_full_unstemmed | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| title_short | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| title_sort | Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer |
| topic | Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Genetic biomarkers DNA Damage and Repair DNA repair Lung Cancer Precision Medicine Translational Research |